-
Something wrong with this record ?
Hb Hradec Kralove (Hb HK) or alpha 2 beta 2 115(G17)Ala-->Asp, a severely unstable hemoglobin variant resulting in a dominant beta-thalassemia trait in a Czech family
V. Divoky, M. Svobodova, K. Indrak, L. Chrobak, TP. Molchanova, TH. Huisman,
Language English Country Great Britain
Document type Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.
Grant support
HLB-05168
NHLBI NIH HHS - United States
- MeSH
- beta-Thalassemia genetics MeSH
- Point Mutation MeSH
- Genes, Dominant MeSH
- Adult MeSH
- Fetal Hemoglobin biosynthesis MeSH
- Globins genetics MeSH
- Hemoglobins, Abnormal genetics isolation & purification MeSH
- Heterozygote MeSH
- Humans MeSH
- Molecular Sequence Data MeSH
- DNA Mutational Analysis MeSH
- Child, Preschool MeSH
- Base Sequence MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Geographicals
- Czech Republic MeSH
We have identified through sequencing of amplified DNA a GCC-->GAC mutation in codon 115 of the beta-globin gene in a mother and daughter of a small Czech family. This base change was confirmed by hybridization with a 32P-labeled specific oligonucleotide probe and by gene mapping because it creates a new Ava II site. The mutation results in an Ala-->Asp replacement at beta 115(G17); this beta chain is severely unstable and could not be identified either as chain or as hemoglobin variant by isoelectrofocusing and various high performance liquid chromatography methods. Stability tests were mildly positive in freshly prepared lysates, but an unstable hemoglobin could not be detected in older lysates with these methods. Its presence results in a dominant type of beta-thalassemia in the two heterozygotes, with moderate anemia, reticulocytosis, nucleated red cells, target cells, and other red cell changes, Heinz body formation, and splenomegaly; the oldest of the two patients was splenectomized. Both subjects had a marked increase in fetal hemoglobin synthesis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20013710
- 003
- CZ-PrNML
- 005
- 20200911093340.0
- 007
- ta
- 008
- 200909s1993 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/03630269308997485 $2 doi
- 035 __
- $a (PubMed)7693620
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Divoky, V $u Laboratory of Protein Chemistry, Medical College of Georgia, Augusta 30912-2100.
- 245 10
- $a Hb Hradec Kralove (Hb HK) or alpha 2 beta 2 115(G17)Ala-->Asp, a severely unstable hemoglobin variant resulting in a dominant beta-thalassemia trait in a Czech family / $c V. Divoky, M. Svobodova, K. Indrak, L. Chrobak, TP. Molchanova, TH. Huisman,
- 520 9_
- $a We have identified through sequencing of amplified DNA a GCC-->GAC mutation in codon 115 of the beta-globin gene in a mother and daughter of a small Czech family. This base change was confirmed by hybridization with a 32P-labeled specific oligonucleotide probe and by gene mapping because it creates a new Ava II site. The mutation results in an Ala-->Asp replacement at beta 115(G17); this beta chain is severely unstable and could not be identified either as chain or as hemoglobin variant by isoelectrofocusing and various high performance liquid chromatography methods. Stability tests were mildly positive in freshly prepared lysates, but an unstable hemoglobin could not be detected in older lysates with these methods. Its presence results in a dominant type of beta-thalassemia in the two heterozygotes, with moderate anemia, reticulocytosis, nucleated red cells, target cells, and other red cell changes, Heinz body formation, and splenomegaly; the oldest of the two patients was splenectomized. Both subjects had a marked increase in fetal hemoglobin synthesis.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fetální hemoglobin $x biosyntéza $7 D005319
- 650 _2
- $a dominantní geny $7 D005799
- 650 _2
- $a globiny $x genetika $7 D005914
- 650 _2
- $a hemoglobiny abnormální $x genetika $x izolace a purifikace $7 D006455
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a bodová mutace $7 D017354
- 650 _2
- $a beta-talasemie $x genetika $7 D017086
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, U.S. Gov't, P.H.S. $7 D013487
- 700 1_
- $a Svobodova, M
- 700 1_
- $a Indrak, K
- 700 1_
- $a Chrobak, L
- 700 1_
- $a Molchanova, T P
- 700 1_
- $a Huisman, T H
- 773 0_
- $w MED00007239 $t Hemoglobin $x 0363-0269 $g Roč. 17, č. 4 (1993), s. 319-328
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/7693620 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200909 $b ABA008
- 991 __
- $a 20200911093339 $b ABA008
- 999 __
- $a ok $b bmc $g 1562058 $s 1103865
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 1993 $b 17 $c 4 $d 319-328 $e - $i 0363-0269 $m Hemoglobin $n Hemoglobin $x MED00007239
- GRA __
- $a HLB-05168 $p NHLBI NIH HHS $2 United States
- LZP __
- $a Pubmed-20200909